NO20070747L - Metode for fremstilling av 2-substituerte derivater av estron og estradiol - Google Patents

Metode for fremstilling av 2-substituerte derivater av estron og estradiol

Info

Publication number: NO20070747L
Authority: NO; Norway
Prior art keywords: compound; general formula; preparing; estrone; estradiol
Prior art date: 2004-08-04

Application number

NO20070747A

Other languages

English (en)

Norwegian (no)

Inventor

Johannes Stoelwinder

Nicolaas Elisabeth Corne Moers

Original Assignee

Organon Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-04

Filing date

2007-02-08

Publication date

2007-04-23

2007-02-08 Application filed by Organon Nv filed Critical Organon Nv

2007-04-23 Publication of NO20070747L publication Critical patent/NO20070747L/no

Links

VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical class OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 title abstract 2
229960005309 estradiol Drugs 0.000 title abstract 2
229930182833 estradiol Chemical class 0.000 title abstract 2
150000002167 estrones Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 9
239000000543 intermediate Substances 0.000 abstract 2
125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical class OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000002947 alkylene group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000004429 atom Chemical group 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
230000001076 estrogenic effect Effects 0.000 abstract 1
229960003399 estrone Drugs 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
- C07J75/005—Preparation of steroids by cyclization of non-steroid compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Pyrane Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20070747A 2004-08-04 2007-02-08 Metode for fremstilling av 2-substituerte derivater av estron og estradiol NO20070747L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04103742		2004-08-04
PCT/EP2005/053732 WO2006013196A1 (en)	2004-08-04	2005-08-01	Process for the preparation 2-substituted-derivatives of estrone and estradiol

Publications (1)

Publication Number	Publication Date
NO20070747L true NO20070747L (no)	2007-04-23

Family

ID=34929415

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20070747A NO20070747L (no)	2004-08-04	2007-02-08	Metode for fremstilling av 2-substituerte derivater av estron og estradiol

Country Status (20)

Country	Link
US (2)	US7910756B2 (de)
EP (1)	EP1776378B1 (de)
JP (1)	JP5075626B2 (de)
KR (1)	KR20070040386A (de)
CN (1)	CN1993376A (de)
AR (1)	AR050195A1 (de)
AT (1)	ATE447580T1 (de)
AU (1)	AU2005268768B2 (de)
BR (1)	BRPI0514096A (de)
CA (1)	CA2573133C (de)
DE (1)	DE602005017500D1 (de)
EC (1)	ECSP077228A (de)
ES (1)	ES2334244T3 (de)
IL (1)	IL180381A0 (de)
MX (1)	MX2007001340A (de)
NO (1)	NO20070747L (de)
RU (1)	RU2007107914A (de)
TW (1)	TW200611909A (de)
WO (1)	WO2006013196A1 (de)
ZA (1)	ZA200700483B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ300376B6 (cs)	2008-05-05	2009-05-06	Prírodovedecká Fakulta Uk	Ligandy estrogenových receptoru alfa a beta, zpusob jejich prípravy a farmaceutické prostredky, které je obsahují
WO2012020417A1 (en)	2010-08-10	2012-02-16	Reliance Life Sciences Pvt. Ltd.	Process for the preparation of estradiol and its derivatives
EP2742352B1 (de) *	2011-08-12	2018-02-28	Siemens Healthcare Diagnostics Inc.	Nachweis von sexualhormonen
CN104592339A (zh) *	2014-12-30	2015-05-06	湖南新合新生物医药有限公司	雌甾-4,9-二烯-3,17-二酮的制备方法
CN104497088B (zh) *	2014-12-30	2016-08-24	湖南新合新生物医药有限公司	19-去甲-4-雄甾烯-3,17-二酮的制备方法
ITUB20155260A1 (it) *	2015-10-30	2017-04-30	Ind Chimica Srl	PROCESSO PER LA PREPARAZIONE DI 17?-idrossi-des-A-androst-9,10-en-5-one
CN108003210A (zh) *	2018-01-24	2018-05-08	四川理工学院	一种雌甾-4,9-二烯-3,17-二酮的制备方法
CN108997463B (zh) *	2018-08-09	2021-05-14	四川理工学院	一种雌甾-4，9-二烯-3，17-二酮制备方法
CN112409434B (zh) *	2020-11-27	2021-10-26	厦门欧瑞捷生物科技有限公司	一种去氢孕酮的合成方法
CN113861158B (zh) *	2021-11-22	2023-02-10	湖南新合新生物医药有限公司	一种合成甲基双烯双酮关键中间体的方法
CN114853802B (zh) *	2022-03-22	2023-11-28	河北康泰药业有限公司	一种谷内酯衍生物及其制备方法、药物组合物和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2997488A (en) *	1959-06-20	1961-08-22	Organon	2-methyl-19-nor-steroids
FR1468608A (fr) *	1960-08-04	1967-02-10	Upjohn Co	2-alpha-fluoro stéroïdes de la série de la 19-norandrostène et leur procédé d'obtention
CH409944A (fr)	1961-04-14	1966-03-31	Roussel Uclaf	Procédé de préparation de dérivés de la 19-nor-testostérone
FR1368721A (fr) *	1961-04-14	1964-08-07	Roussel Uclaf	Dérivés de la 19-nor testostérone et procédé de préparation
US3519714A (en) *	1966-03-15	1970-07-07	Herchel Smith	Synthesis of gona-1,3,5(10)-trienes
US4400524A (en) *	1981-07-28	1983-08-23	The Upjohn Company	Grignard reagents prepared from 5-halopentan-2-one propylene ketals
DE3208432A1 (de)	1982-03-09	1983-09-15	The Upjohn Co., 49001 Kalamazoo, Mich.	Verfahren zur herstellung von 19-norandrostendion, zwischenprodukt des 19-norandrostendions und verfahren zu seiner herstellung
US5504074A (en) *	1993-08-06	1996-04-02	Children's Medical Center Corporation	Estrogenic compounds as anti-angiogenic agents
US5521168A (en) *	1994-10-13	1996-05-28	Alcon Laboratories, Inc.	Estrogen metabolites for lowering intraocular pressure
US5998639A (en) *	1995-11-06	1999-12-07	Akzo Nobel, N.V.	Sulfatation of estrogen mixtures
IL119649A (en)	1995-11-30	2002-03-10	Akzo Nobel Nv	Preparation of Cyclic Kills of History - 3 keto- (5) 10, (-9) 11 steroidadians
US6051726A (en) *	1997-03-13	2000-04-18	Pharm-Eco Laboratories, Inc.	Synthesis of 2-alkoxyestradiols
US7087592B1 (en) *	1999-08-23	2006-08-08	Entre Med, Inc.	Compositions comprising purified 2-methoxyestradiol and methods of producing same
AU7572600A (en)	1999-08-23	2001-03-19	Entremed, Inc	Methods of obtaining 2-methoxyestradiol of high purity
EP1343803A2 (de)	2000-11-27	2003-09-17	EntreMed, Inc.	2-substituierte estrogene mit antiangiogenischer aktivität

2005
- 2005-07-14 TW TW094123942A patent/TW200611909A/zh unknown
- 2005-08-01 JP JP2007524335A patent/JP5075626B2/ja not_active Expired - Fee Related
- 2005-08-01 US US11/659,147 patent/US7910756B2/en not_active Expired - Fee Related
- 2005-08-01 EP EP05767940A patent/EP1776378B1/de not_active Expired - Lifetime
- 2005-08-01 AT AT05767940T patent/ATE447580T1/de not_active IP Right Cessation
- 2005-08-01 WO PCT/EP2005/053732 patent/WO2006013196A1/en not_active Ceased
- 2005-08-01 KR KR1020077002976A patent/KR20070040386A/ko not_active Ceased
- 2005-08-01 AU AU2005268768A patent/AU2005268768B2/en not_active Ceased
- 2005-08-01 ES ES05767940T patent/ES2334244T3/es not_active Expired - Lifetime
- 2005-08-01 CA CA2573133A patent/CA2573133C/en not_active Expired - Fee Related
- 2005-08-01 DE DE602005017500T patent/DE602005017500D1/de not_active Expired - Lifetime
- 2005-08-01 CN CNA2005800261640A patent/CN1993376A/zh active Pending
- 2005-08-01 MX MX2007001340A patent/MX2007001340A/es active IP Right Grant
- 2005-08-01 RU RU2007107914/04A patent/RU2007107914A/ru not_active Application Discontinuation
- 2005-08-01 BR BRPI0514096-0A patent/BRPI0514096A/pt not_active IP Right Cessation
- 2005-08-04 AR ARP050103233A patent/AR050195A1/es unknown
2006
- 2006-12-27 IL IL180381A patent/IL180381A0/en unknown
2007
- 2007-01-16 ZA ZA200700483A patent/ZA200700483B/xx unknown
- 2007-02-05 EC EC2007007228A patent/ECSP077228A/es unknown
- 2007-02-08 NO NO20070747A patent/NO20070747L/no not_active Application Discontinuation
2011
- 2011-02-22 US US13/031,975 patent/US20110152544A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2573133A1 (en)	2006-02-09
ZA200700483B (en)	2008-09-25
MX2007001340A (es)	2007-03-27
DE602005017500D1 (de)	2009-12-17
JP2008509109A (ja)	2008-03-27
AU2005268768B2 (en)	2011-10-13
RU2007107914A (ru)	2008-09-10
US20090012319A1 (en)	2009-01-08
IL180381A0 (en)	2007-06-03
BRPI0514096A (pt)	2008-05-27
US7910756B2 (en)	2011-03-22
CN1993376A (zh)	2007-07-04
CA2573133C (en)	2012-07-10
WO2006013196A1 (en)	2006-02-09
EP1776378B1 (de)	2009-11-04
TW200611909A (en)	2006-04-16
US20110152544A1 (en)	2011-06-23
ATE447580T1 (de)	2009-11-15
KR20070040386A (ko)	2007-04-16
EP1776378A1 (de)	2007-04-25
JP5075626B2 (ja)	2012-11-21
ES2334244T3 (es)	2010-03-08
AU2005268768A1 (en)	2006-02-09
AR050195A1 (es)	2006-10-04
ECSP077228A (es)	2007-03-29

Legal Events

Date	Code	Title	Description
2010-03-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20070747L (no)	2007-04-23	Metode for fremstilling av 2-substituerte derivater av estron og estradiol
US5446036A (en)	1995-08-29	13-alkyl-11beta-phenylgonanes
AU2001253427B2 (en)	2007-02-08	A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group
Di Matteo et al.	2016	Synthesis and biological characterization of 3-(imidazol-1-ylmethyl) piperidine sulfonamides as aromatase inhibitors
WO2005105822A3 (en)	2006-02-02	3-alpha-hydroxy 21-n- heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof
TW200722086A (en)	2007-06-16	Compounds comprising an oxazole or thiazole moiety, processes for making them and their uses
FR2618783A1 (fr)	1989-02-03	Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
Mizoguchi et al.	2015	Synthesis of multiply substituted 1, 6-dihydropyridines through Cu (I)-catalyzed 6-endo cyclization
JP6556125B2 (ja)	2019-08-07	１７β−ヒドロキシステロイドデヒドロゲナーゼの阻害剤としての治療的に活性な１７−窒素置換エストラトリエンチアゾール誘導体
DE1618830A1 (de)	1972-04-13	Verfahren zur Herstellung von in 11-Stellung substituierten Steroidderivaten mit aromatischem Kern A
TW201710280A (zh)	2017-03-16	膽酸及其衍生物之製備方法
Quindt et al.	2019	Photo-fries rearrangement of some 3-acylestrones in homogeneous media: preparative and mechanistic studies
Haveli et al.	2013	Ring opening of activated cyclopropanes with NIS/NaN3: synthesis of C-1 linked pseudodisaccharides
WO2010141494A2 (en)	2010-12-09	Synthesis of ezetimibe
Bruttomesso et al.	2009	Highly stereoselective synthesis of steroidal 2, 5-diketopiperazines based on isocyanide chemistry
Luo et al.	2007	Facile preparation of α-amino ketones from oxidative ring-opening of aziridines by pyridine N-oxide
EP0087359B1 (de)	1989-05-31	Reagenz zur Nitromethylierung, seine Anwendung zur Herstellung von nitromethylierten Verbindungen von bestimmten Derivaten davon und die erhaltenen Verbindungen
JP2999258B2 (ja)	2000-01-17	１０β―Ｈ―ステロイドの製法
Williams et al.	2003	Synthesis of the aglycone of 26-O-deacetyl pavoninin-5
Nué Martínez et al.	2021	High yield synthesis of trans-azoxybenzene versus 2-isopropoxy-4-nitrobenzoic acid: influence of temperature and base concentration
Frank et al.	2007	New steroid-fused P-heterocycles: Part II. Synthesis and conformational study of oxazaphosphorino [16, 17-e] estrone derivatives
Dittrich et al.	2015	Traceless bond construction via rearrangement of N-Boc-N-allylhydrazones giving 1, 1-disubstituted olefins
RU2858792C1 (ru)	2026-03-24	1-[3'-Метокси-13'-гидрокси-13',17'-секоэстра-1',3',5'(10')-триено-17'-ил]-5-гидрокси-4,5-дигидро-1Н-пиразолы
JP4913389B2 (ja)	2012-04-11	アセトキシキャビコールアセテート類縁体化合物、その製造方法、および抗アレルギー剤
EP2354150A1 (de)	2011-08-10	Verfahren zur Herstellung von Gestoden